Oculyze receives investment boost
Oculyze announced that it had secured a seven figure investment from Constantia New Business (CNB) GmbH headquartered in Vienna, Austria. CNB is a venture capital investor working with high-tech startups inspired by the idea of creating impactful companies and joins Oculyze’s existing investor since 2017 BFB Brandenburg Kapital GmbH. The funds will be utilized to support Oculyze’s plans to grow the current business exponentially, specifically supporting late-stage research and development of additional products in the Oculyze portfolio and further market expansion both within Germany and across the world.
Kilian Moser, co-founder and Chief Executive Officer of Oculyze
Oculyze
Commenting on the latest development, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said: “As we embark on a new year, I am delighted to announce that we have secured further funding through a new partnership with Austrian based CNB. This latest funding comes at a very exciting time for Oculyze as we seek to consolidate and sustain our position as the world’s premier platform for mobile image analysis.
During 2018, we strengthened our core team through the hiring of senior professionals, bringing in a wealth of experience and expertise crucial to the future growth of Oculyze. In addition, and after developing and enhancing our technology, we rolled out our flagship product – the Oculyze Better Brewing (BB) 2.0 as well as signed on a global distribution partner to extend our product to an even bigger audience across the world. During the last quarter of 2018, we launched our online store, automating and streamlining the entire purchase-to-fulfillment process within a safe and secure environment. All these developments have resulted in a steady increase in sales and a customer reach across 26 countries.
We take this opportunity to thank the team at CNB for their invaluable support and will continue to focus on creating greater value for all our stakeholders.”
Speaking at the signing, Sabine Fleischmann, Senior Investment Manager at CNB said: “We are thrilled to collaborate with an innovative German firm like Oculyze as it looks to delivering on its vision to provide automated image analysis to anyone anywhere. As an independent Austrian venture capital investor, we are always on the look-out for innovative young companies across Europe that are backed by an experienced and professional team who fit our investment and business model and seek a partner to support them both financially and as a hands-on partner during the next growth stage. We are glad to extend our full support to them and look forward to a fruitful partnership”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
